Herein, we not only evaluated ccRCC specifically, but also the association of these 14 variants with specific molecular (BAP1, PBRM1, SETD2 and VHL) and clinically-aggressive subtypes of ccRCC. This evidence concerns the gene PBRM1 and nonpapillary renal cell carcinoma.